How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?

Journal: Transfusion •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Bruneau L, Charlton CL, Ramirez-Arcos S, et al. (2026). "How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?". Transfusion. https://doi.org/10.1111/trf.70388